IL111908A - Optionally substituted phenylimidazolidines, their preparation process and intermediates, and method of inducing antiandrogenic activity in warmblooded animals - Google Patents

Optionally substituted phenylimidazolidines, their preparation process and intermediates, and method of inducing antiandrogenic activity in warmblooded animals

Info

Publication number: IL111908A
Authority: IL; Israel
Prior art keywords: optionally substituted; pct; intermediates; preparation process; antiandrogenic activity
Prior art date: 1994-01-05

Application number

IL11190894A

Other languages

English (en)

Other versions

IL111908A0 (en

Original Assignee

Hoechst Marion Roussel Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-01-05

Filing date

1994-12-07

Publication date

2003-05-29

1994-01-05 Priority claimed from FR9400042A external-priority patent/FR2715402B1/fr

1994-09-06 Priority claimed from FR9410660A external-priority patent/FR2724169B1/fr

1994-12-07 Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc

1995-03-15 Publication of IL111908A0 publication Critical patent/IL111908A0/xx

2003-05-29 Publication of IL111908A publication Critical patent/IL111908A/xx

Links

230000002280 anti-androgenic effect Effects 0.000 title abstract 2
TVPNGVPSNXPYLT-UHFFFAOYSA-N 1-phenylimidazolidine Chemical class C1NCCN1C1=CC=CC=C1 TVPNGVPSNXPYLT-UHFFFAOYSA-N 0.000 title 1
241001465754 Metazoa Species 0.000 title 1
230000001939 inductive effect Effects 0.000 title 1
239000000543 intermediate Substances 0.000 title 1
238000000034 method Methods 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
229910052736 halogen Inorganic materials 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

IL11190894A 1994-01-05 1994-12-07 Optionally substituted phenylimidazolidines, their preparation process and intermediates, and method of inducing antiandrogenic activity in warmblooded animals IL111908A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9400042A FR2715402B1 (fr)	1994-01-05	1994-01-05	Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR9410660A FR2724169B1 (fr)	1994-09-06	1994-09-06	Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number	Publication Date
IL111908A0 IL111908A0 (en)	1995-03-15
IL111908A true IL111908A (en)	2003-05-29

Family

ID=26230882

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11190894A IL111908A (en)	1994-01-05	1994-12-07	Optionally substituted phenylimidazolidines, their preparation process and intermediates, and method of inducing antiandrogenic activity in warmblooded animals

Country Status (20)

Country	Link
US (1)	US5750553A (es)
EP (1)	EP0738263B1 (es)
JP (1)	JPH09507241A (es)
KR (1)	KR100372065B1 (es)
CN (1)	CN1113873C (es)
AT (1)	ATE200281T1 (es)
AU (1)	AU687152B2 (es)
BR (1)	BR9506457A (es)
CA (1)	CA2180379A1 (es)
DE (1)	DE69520560T2 (es)
DK (1)	DK0738263T3 (es)
ES (1)	ES2156204T3 (es)
FI (1)	FI112475B (es)
GR (1)	GR3035853T3 (es)
HU (1)	HUT76299A (es)
IL (1)	IL111908A (es)
MA (1)	MA23423A1 (es)
PT (1)	PT738263E (es)
TW (1)	TW521073B (es)
WO (1)	WO1995018794A1 (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2741342B1 (fr) *	1995-11-22	1998-02-06	Roussel Uclaf	Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
FR2742749B1 (fr) *	1995-12-22	1998-02-06	Roussel Uclaf	Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques
ES2191286T3 (es) *	1997-03-03	2003-09-01	Boehringer Ingelheim Pharma	Moleculas pequeñas, utiles en el tratamiento de enfermedades inflamatorias.
USRE38132E1 (en)	1997-03-03	2003-06-03	Boehringer Ingelheim Pharmaceuticals, Inc.	Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
US6355664B1 (en)	1997-03-03	2002-03-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
IL142598A0 (en) *	1998-10-23	2002-03-10	Aventis Pharma Gmbh	Preparations for topical application of substances having antiandrogenic effect
US6184249B1 (en) *	1998-12-18	2001-02-06	Biophysica, Inc.	Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
WO2001007052A1 (en)	1999-07-21	2001-02-01	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
US6492408B1 (en) *	1999-07-21	2002-12-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
WO2001007044A1 (en)	1999-07-21	2001-02-01	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
JP3833532B2 (ja)	1999-07-21	2006-10-11	ベーリンガーインゲルハイムファーマシューティカルズインコーポレイテッド	炎症性疾患の治療において有用な小分子
US6828458B2 (en)	2000-05-25	2004-12-07	Biophysica, Inc.	Topical antiandrogen for hair loss and other hyperandrogenic conditions
US7001911B2 (en) *	2000-06-28	2006-02-21	Bristol-Myers Squibb Company	Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en)	2001-06-20	2004-04-22	Salvati Mark E.	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
MXPA02012605A (es)	2000-06-28	2003-05-14	Squibb Bristol Myers Co	Moduladores selectivos del receptor androgeno y metodo para su identificacion, dise°o y uso.
US6953679B2 (en)	2000-09-19	2005-10-11	Bristol-Myers Squibb Company	Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (en) *	2000-09-19	2007-11-28	Bristol-Myers Squibb Company	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040087548A1 (en)	2001-02-27	2004-05-06	Salvati Mark E.	Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
DE10141443B4 (de) *	2001-08-23	2007-02-01	Christos C. Prof. Dr. Zouboulis	Verwendung von molekularbiologisch hergestellten, nicht-viralen Wirkstoffen zur Behandlung der Akne
HRP20040311A2 (en) *	2001-10-01	2005-02-28	Bristol-Myers Squibb Company Cerep SA	Spiro-hydantoin compounds useful as anti-inflammatory agents
US7087636B2 (en)	2001-12-19	2006-08-08	Bristol-Myers Squibb Company	Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
US6875438B2 (en) *	2002-04-27	2005-04-05	Aventis Pharma Deutschland Gmbh	Preparations for topical administration of substances having antiandrogenic activity
ATE502298T1 (de) *	2003-12-19	2011-04-15	Univ California	Verfahren und materialien zur beurteilung von prostatakrebstherapien
AU2011202578B2 (en) *	2004-02-24	2012-03-22	The Regents Of The University Of California	Methods and materials for assessing prostate cancer therapies and compounds
NZ550102A (en) *	2004-02-24	2010-10-29	Univ California	Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US8470829B2 (en)	2004-09-09	2013-06-25	Chugai Seiyaku Kabushiki Kaisha	Imidazolidine derivative and use thereof
CA2579514A1 (en) *	2004-09-10	2006-03-23	Janssen Pharmaceutica N.V.	Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms)
TW200616634A (en) *	2004-10-01	2006-06-01	Bristol Myers Squibb Co	Crystalline forms and process for preparing spiro-hydantoin compounds
US20060142319A1 (en) *	2004-12-14	2006-06-29	Bang-Chi Chen	Pyridyl-substituted spiro-hydantoin crystalline forms and process
US7186727B2 (en) *	2004-12-14	2007-03-06	Bristol-Myers Squibb Company	Pyridyl-substituted spiro-hydantoin compounds and use thereof
US7709517B2 (en) *	2005-05-13	2010-05-04	The Regents Of The University Of California	Diarylhydantoin compounds
US7709516B2 (en)	2005-06-17	2010-05-04	Endorecherche, Inc.	Helix 12 directed non-steroidal antiandrogens
SI2656842T1 (sl)	2006-03-27	2016-10-28	The Regents Of The University Of California	Modulator androgenih receptorjev za zdravljenje raka prostate in bolezni, povezanih z androgenimi receptorji
WO2007127010A2 (en)	2006-03-29	2007-11-08	The Regents Of The University Of California	Diarylthiohydantoin compounds
GB0610765D0 (en) *	2006-05-31	2006-07-12	Proskelia Sas	Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
US8168667B2 (en) *	2006-05-31	2012-05-01	Galapagos Nv	Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
US9284345B2 (en)	2007-04-12	2016-03-15	Endorecherche, Inc.	17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
EP2620432A3 (en)	2007-10-26	2013-12-18	The Regents Of the University of California	Diarylhydantoin compounds
MX2010004995A (es) *	2007-11-29	2010-05-20	Boehringer Ingelheim Int	Derivados de amidas del acido 6,7-dihidro-5h-imidazo[1,2-a]imidazo l-3-carboxilico.
GB2463514C (en) *	2008-09-11	2018-09-26	Galapagos Nv	Imidazolidine compounds and uses therefor
FR2944524B1 (fr) *	2009-04-17	2012-11-30	Ipsen Pharma Sas	Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament
WO2010141330A1 (en)	2009-06-02	2010-12-09	Boehringer Ingelheim International Gmbh	DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
BRPI1012581A2 (pt)	2009-06-02	2016-03-29	Boehringer Ingelheim Int	derivados de amidas de ácido 6, 7-di-hidro-5h-imidazol[1,2-a]imidazol-3-carboxílico
RU2012114770A (ru)	2009-09-04	2013-10-10	Вандербилт Юниверсити	АЛЛОСТЕРИЧЕСКИЕ СРЕДСТВА ПОТЕНЦИРОВАНИЯ mGluR4, КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ ДИСФУНКЦИЙ
US8809550B2 (en)	2009-09-10	2014-08-19	Youzhi Tong	Androgen receptor antagonists and uses thereof
TW201111378A (en)	2009-09-11	2011-04-01	Bayer Schering Pharma Ag	Substituted (heteroarylmethyl) thiohydantoins
AU2011218173C1 (en)	2010-02-16	2015-04-16	Aragon Pharmaceuticals, Inc.	Androgen receptor modulators and uses thereof
RU2434851C1 (ru) *	2010-07-22	2011-11-27	Александр Васильевич Иващенко	Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения
EP2683694B1 (en)	2011-03-10	2016-04-27	Suzhou Kintor Pharmaceuticals, Inc.	Androgen receptor antagonists and uses thereof
UY34646A (es)	2012-03-02	2013-10-31	Novartis Ag	Compuestos de espirohidantoína y su uso como moduladores selectivos del receptor de andrógenos
NZ744456A (en)	2012-09-26	2019-09-27	Aragon Pharmaceuticals Inc	Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL2945628T3 (pl)	2013-01-15	2020-09-21	Aragon Pharmaceuticals, Inc.	Modulator receptorów androgenowych w skojarzeniu z octanem abirateronu i prednizonem do leczenia nowotworu stercza
US9682960B2 (en)	2013-12-19	2017-06-20	Endorecherche, Inc.	Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
TWI726969B (zh)	2016-01-11	2021-05-11	比利時商健生藥品公司	用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
US10702508B2 (en)	2017-10-16	2020-07-07	Aragon Pharmaceuticals, Inc.	Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
US11981660B2 (en)	2018-03-21	2024-05-14	University Of Miami	Neurite outgrowth promoters and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1032258B (de) *	1956-12-20	1958-06-19	Kali Chemie Ag	Verfahren zur Herstellung von in 5-Stellung mono- und disubstituierten 1-Aryl-hydantoinen
GB997037A (en) *	1962-03-19	1965-06-30	Ici Ltd	New hydrantoin derivatives
DK123717B (da) *	1968-11-25	1972-07-24	Sumitomo Chemical Co	3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
JPS5136332B1 (es) *	1970-12-09	1976-10-07
US4093444A (en) *	1973-05-22	1978-06-06	Pepro, Societe Pour Le Developpement Et La Vente De Specialites Chimiques	Hydantoin derivatives and methods for regulating plant-growth
FR2329276A1 (fr) *	1975-10-29	1977-05-27	Roussel Uclaf	Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
DE2540872A1 (de) *	1975-09-13	1977-03-24	Basf Ag	Hydantoin-derivate
JPS52113965A (en) *	1976-03-22	1977-09-24	Nippon Soda Co Ltd	Hydantoin derivatives, their preparation, fungicides for agriculture a nd gardening use containing the same
JPS53112875A (en) *	1977-03-15	1978-10-02	Sumitomo Chem Co Ltd	1-chlorocarbonylmethyl-3-(3,5-dichlorophenyl)hydantoin, its preparation and industrial bactericide containing the same
JPS53124267A (en) *	1977-04-06	1978-10-30	Sumitomo Chem Co Ltd	1-alkoxyacyl-3-(3,5-dihalogenophenyl)hydantoin derivatives, their preparation and bactericides for agricultural and horticultural uses containing the same as active agent
JPS5427564A (en) *	1977-08-02	1979-03-01	Sumitomo Chem Co Ltd	1-branched alkylcarbonyl-3-(3,5-dihalogenophenyl) hydantoins, their preparation, and bactericides for pomicultural and horticultural uses containing the same as active agent.
MC1220A1 (fr) *	1977-10-28	1979-07-20	Hoffmann La Roche	Nouveaux derives d'imidazolidine
FI801184A7 (fi) *	1979-04-24	1981-01-01	F Hoffmann La Roche & Co	Menetelmä imidatsolidiini-johdannaisten valmistamiseksi.
BE884897R (fr) *	1980-08-22	1981-02-23	Hoffmann La Roche	Preparations pharmaceutiques
US4753957A (en) *	1981-09-28	1988-06-28	Rohm And Haas Company	Substituted 2,4-imidazolidinediones and fungicidal compositions
EP0091596B1 (de) *	1982-04-08	1991-09-11	Shell Internationale Researchmaatschappij B.V.	Neue Hydantoine, ihre Herstellung und Verwendung
FR2619381B1 (fr) *	1987-08-13	1989-12-08	Roussel Uclaf	Nouvelles imidazolidines substituees par un radical hydroxymethyle et un radical phenyl substitue, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant et un intermediaire pour leur preparation
FR2671348B1 (fr) *	1991-01-09	1993-03-26	Roussel Uclaf	Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US5411981A (en) *	1991-01-09	1995-05-02	Roussel Uclaf	Phenylimidazolidines having antiandrogenic activity
FR2693461B1 (fr) *	1992-07-08	1994-09-02	Roussel Uclaf	Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR2694290B1 (fr) *	1992-07-08	1994-09-02	Roussel Uclaf	Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.

1994
- 1994-12-05 TW TW083111272A patent/TW521073B/zh not_active IP Right Cessation
- 1994-12-07 IL IL11190894A patent/IL111908A/xx not_active IP Right Cessation
1995
- 1995-01-03 MA MA23750A patent/MA23423A1/fr unknown
- 1995-01-04 PT PT95906361T patent/PT738263E/pt unknown
- 1995-01-04 KR KR1019960703612A patent/KR100372065B1/ko not_active Expired - Fee Related
- 1995-01-04 US US08/669,419 patent/US5750553A/en not_active Expired - Fee Related
- 1995-01-04 WO PCT/FR1995/000004 patent/WO1995018794A1/fr not_active Ceased
- 1995-01-04 AT AT95906361T patent/ATE200281T1/de not_active IP Right Cessation
- 1995-01-04 ES ES95906361T patent/ES2156204T3/es not_active Expired - Lifetime
- 1995-01-04 EP EP95906361A patent/EP0738263B1/fr not_active Expired - Lifetime
- 1995-01-04 CA CA002180379A patent/CA2180379A1/fr not_active Abandoned
- 1995-01-04 HU HU9601836A patent/HUT76299A/hu unknown
- 1995-01-04 DK DK95906361T patent/DK0738263T3/da active
- 1995-01-04 JP JP7518337A patent/JPH09507241A/ja active Pending
- 1995-01-04 BR BR9506457A patent/BR9506457A/pt not_active IP Right Cessation
- 1995-01-04 AU AU14573/95A patent/AU687152B2/en not_active Ceased
- 1995-01-04 DE DE69520560T patent/DE69520560T2/de not_active Expired - Fee Related
- 1995-01-04 CN CN95191761A patent/CN1113873C/zh not_active Expired - Fee Related
1996
- 1996-07-04 FI FI962754A patent/FI112475B/fi not_active IP Right Cessation
2001
- 2001-05-11 GR GR20010400704T patent/GR3035853T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU1457395A (en)	1995-08-01
DE69520560T2 (de)	2001-09-13
EP0738263B1 (fr)	2001-04-04
HUT76299A (en)	1997-07-28
DK0738263T3 (da)	2001-06-18
EP0738263A1 (fr)	1996-10-23
HU9601836D0 (en)	1996-09-30
ES2156204T3 (es)	2001-06-16
IL111908A0 (en)	1995-03-15
US5750553A (en)	1998-05-12
WO1995018794A1 (fr)	1995-07-13
FI112475B (fi)	2003-12-15
AU687152B2 (en)	1998-02-19
CN1141631A (zh)	1997-01-29
CA2180379A1 (fr)	1995-07-13
DE69520560D1 (de)	2001-05-10
KR100372065B1 (ko)	2003-05-12
GR3035853T3 (en)	2001-08-31
MA23423A1 (fr)	1995-10-01
TW521073B (en)	2003-02-21
FI962754L (fi)	1996-07-04
PT738263E (pt)	2001-08-30
CN1113873C (zh)	2003-07-09
ATE200281T1 (de)	2001-04-15
JPH09507241A (ja)	1997-07-22
BR9506457A (pt)	1997-10-07
FI962754A0 (fi)	1996-07-04

Legal Events

Date	Code	Title
2000-06-01	HCE	Change of name and address of proprietor(s)
2003-11-23	FF	Patent granted
2003-12-10	KB	Patent renewed
2005-02-20	KB	Patent renewed
2010-02-14	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
IL111908A (en)	2003-05-29	Optionally substituted phenylimidazolidines, their preparation process and intermediates, and method of inducing antiandrogenic activity in warmblooded animals
TW340842B (en)	1998-09-21	Substituted benzylaminopiperidine compounds
NZ511739A (en)	2002-11-26	New esters derived from substituted phenyl-cyclohexyl compounds
BR9609037A (pt)	1999-07-06	Processo para a preparação de um 2-(6-substituído pirid-2-iloximetil)fenil acetato e composto
EP0790246A4 (en)	1998-03-11	POTENTIALIZER OF THE ACTIVITY OF THE NERVOUS GROWTH FACTOR CONTAINING A DERIVATIVE OF 1,2-ETHANEDIOL OR A SALT THEREOF
YU38798A (sh)	2001-05-28	Novi postupci za dobijanje pesticidnih intermedijera
GR3017766T3 (en)	1996-01-31	Process for preparing sertraline.
TW284765B (es)	1996-09-01
BR9507168A (pt)	1997-09-02	Composto e processo para a preparação do mesmo
NZ237819A (en)	1993-05-26	Process for the preparation of 4-(aminoalkyl)-1,3-dihydro-2h-indol-2-one derivatives, and intermediates therefor
GR3033006T3 (en)	2000-07-31	Process for producing alkoxyiminoacetamide derivative
ZA89845B (en)	1990-10-31	Agents for reducing transpiration of plants
MA24904A1 (fr)	2000-04-01	Procede de preparation d'intermediaires pesticides
JPS5488240A (en)	1979-07-13	Novel fortimicin a derivative
DE69505695D1 (de)	1998-12-03	Halogenierte ester als nützliche zwischenprodukte für insektizide
GR3036896T3 (en)	2002-01-31	A novel asymmetric synthesis of r and s warfarin and its analogs
GB9603637D0 (en)	1996-04-17	Process
HU9401470D0 (en)	1994-08-29	1-phenylpyrrolidone derivatives, intermediates for producing them and producing them